Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Study says novel personalised cancer vaccine safe

IANS
Updated: April 12th, 2021, 16:21 IST
in Feature
0
Representative pic

Pic Credit: homage.sg

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New York: A new personalised cancer vaccine, developed by the US researchers, is safe and beneficial for patients with different cancers, including lung and bladder, results of phase I clinical trials have shown.

“While immunotherapy has revolutionised the treatment of cancer, the vast majority of patients do not experience a significant clinical response with such treatments,” said Thomas Marron, Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, in New York, US.

Also Read

Viral video

Viral video: RPF constable shows no mercy to passenger on moving train

18 hours ago
Viral video

Viral video: This Google Street View captured love story will break your heart!

18 hours ago

“Cancer vaccines, which typically combine tumour-specific targets that the immune system can learn to recognise and attack to prevent recurrence of cancer. The vaccine also contains an adjuvant that primes the immune system to maximise the efficacy,” Maron said.

In the phase 1 trial, 13 patients received the vaccine: 10 had solid tumour diagnoses and three had multiple myeloma, before the vaccine.

The team sequenced all the 13 patient’s tumour and germline DNA and tumour RNA and administered them 10 doses of the personalised vaccine over a six-month period.A

The vaccine was given with the immunostimulant, or adjuvant, poly-ICLC, which is “a synthetic, stabilised, double-stranded RNA capable of activating multiple innate immune receptors, making it the optimal adjuvant for inducing immune responses against tumour neoantigens,” said Nina Bhardwaj, Director of the Immunotherapy Programme and at The Tisch Cancer Institute at Mount Sinai.

After a follow-up of nearly two-and a half years, four patients still had no evidence of cancer, four were receiving subsequent lines of therapy, four had died, and one chose not to continue the trial.

The vaccine was well tolerated, with roughly one-third of patients developing minor injection-site reactions, the researchers said.

The results were presented at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021 held between April 10 and 15.

 

Tags: cancer vaccineUS researchers
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Shreyanshu Bal

December 12, 2019
#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Anup Mahapatra

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Surya Sidhant Rath

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

Pragyan Priyambada

December 12, 2019
#MyPaperBagChallenge

Anasuya Sahoo

December 12, 2019
#MyPaperBagChallenge

Pratyasharani Ghibela

December 12, 2019
#MyPaperBagChallenge

Matrumangal Jena

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Aishwarya Ranjan Mohanty

December 12, 2019
#MyPaperBagChallenge

Priyabrata Mohanty

December 12, 2019
#MyPaperBagChallenge

Smitarani Sahoo

December 12, 2019
#MyPaperBagChallenge

Saishree Satyarupa

December 12, 2019
#MyPaperBagChallenge

Jyotshna Mayee Pattnaik

December 12, 2019
#MyPaperBagChallenge

Spinoj Pattnaik

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Pratik Kumar

December 12, 2019
#MyPaperBagChallenge

Ipsita

December 12, 2019

Archives

Editorial

CIC on Life Support

Silent Shift
August 23, 2025

As of September 14, the Central Information Commission (CIC) may be headless. Chief Information Commissioner Heeralal Samariya retires, and unless...

Read moreDetails

‘TACO’ Effect

August 20, 2025

It is interesting to note US President Donald Trump keeps changing his deadline for imposing new tariffs on goods from...

Read moreDetails

Plastic Threat

Plastic
August 19, 2025

More than 400 million tons of plastic are produced globally each year, half of which is for single-use items. Nearly...

Read moreDetails

Road To Peace?

Putin-Trump summit: India welcomes progress
August 18, 2025

US President Donald Trump and his Russian counterpart Vladimir Putin’s much-anticipated summit in Anchorage, Alaska, on 15 August was warm...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST